Track cost pressure
Identify presentations with rising spend and create intervention plans focused on switching opportunities or formulary alignment.
Explore British National Formulary presentations, drill into dispensing trend data, and identify which pharmacies drive the greatest usage of each medicine.
| Presentation | Product | Chemical substance | Chapter | Items dispensed |
|---|---|---|---|---|
|
Betamethasone valerate 0.1% oint 50% in White soft paraffin
1304000F0AACZCZ
|
Betamethasone valerate (Topical) | Betamethasone valerate | Skin | 3 |
|
Blistex Relief cream
131003000BLBJA0
|
Proprietary compound preparation BNF 1310030 | Other antiviral preparations | Skin | 3 |
|
Calamine and Coal tar ointment
1305020C0AAACAC
|
Coal tar/tar (Topical) | Tars | Skin | 3 |
|
Camphor 3.57%/Salicylic acid 3.57%/Phenol 2.85%/Sulfur 2.14%
130900000AABGBG
|
Generic compound preparation BNF 1309000 | Other shampoo and scalp preparations | Skin | 3 |
|
ChloraPrep solution 0.67ml applicators
1311020L0CHABBW
|
ChloraPrep | Chlorhexidine gluconate | Skin | 3 |
|
Coal tar 10% in Betamethasone valerate 0.025% ointment
1304000F0AAETET
|
Betamethasone valerate (Topical) | Betamethasone valerate | Skin | 3 |
|
Coal tar 12% / Salicylic acid 3% in White soft paraffin
1305020C0AAGIGI
|
Coal tar/tar (Topical) | Tars | Skin | 3 |
|
Coal tar solution 3% / Salicylic acid 3% in Aqueous cream
1305020C0AAHFHF
|
Coal tar/tar (Topical) | Tars | Skin | 3 |
|
Coal tar solution 5% in Betamethasone valerate 0.025% cream
1304000F0AAEPEP
|
Betamethasone valerate (Topical) | Betamethasone valerate | Skin | 3 |
|
Dithrocream 2% cream
1305020F0BIAEDB
|
Dithrocream | Dithranol | Skin | 3 |
|
E45 Intense Recovery lotion
130201000BBLCA0
|
Proprietary compound emollients | Other emollient preparations | Skin | 3 |
|
Evening primrose oil 20% cream
130201000AACGCG
|
Generic compound emollients | Other emollient preparations | Skin | 3 |
|
Formaldehyde solution
1307000C0AAACAC
|
Formaldehyde (Topical) | Formaldehyde | Skin | 3 |
|
Generic Sudocrem antiseptic healing cream
1302020E0AAALAL
|
Zinc oxide | Zinc oxide | Skin | 3 |
|
Halogenated phenols 0.68% / Phenol 0.175% liquid
1311050V0AAAAAA
|
Halogenated phenols with phenol | Halogenated phenols with phenol | Skin | 3 |
|
Ichthammol 1% paste
1305010J0AAAVAV
|
Ichthammol (Topical) | Ichthammol | Skin | 3 |
|
Ichthammol 10% ointment
1305010J0AAAAAA
|
Ichthammol (Topical) | Ichthammol | Skin | 3 |
|
Lactic acid 5% in Aqueous cream
1302010K0AAAHAH
|
Lactic acid (Topical) | Lactic acid | Skin | 3 |
|
Larvae 100 30cm x 30cm dressing pack
1311070S0BBAWAA
|
LarvE | Ster larvae | Skin | 3 |
|
Monobenzone 20% in Aqueous cream
131500000AABSBS
|
Generic compound preparation BNF 1315000 | Other miscellaneous topical preparations | Skin | 3 |
|
Salicylic acid 3% / Sulfur 3% ointment
1306010T0AAABAB
|
Sulfur (Topical) | Sulfur | Skin | 3 |
|
Salicylic acid 5% in Generic Unguentum M cream
1305020S0AACWCW
|
Salicylic acid (Psoriasis) | Salicylic acid | Skin | 3 |
|
Sulfur 1% in Hydrocortisone 1% cream
1304000V0AAEYEY
|
Hydrocortisone (Topical) | Hydrocortisone | Skin | 3 |
|
Synalar 1 in 10 Dilution 0.0025% cream
1304000N0BBAEAE
|
Synalar | Fluocinolone acetonide | Skin | 3 |
|
Thovaline ointment
1302020F0BDABA0
|
Thovaline | Cod liver oil | Skin | 3 |
Link medicine usage to pharmacy and prescriber behaviour to find optimisation opportunities.
Identify presentations with rising spend and create intervention plans focused on switching opportunities or formulary alignment.
Cross-reference high-volume medicines with local health priorities and prescriber activity to target support programs.